United States: Marion − Even With A Road Map, Only One Dubious Claim Navigates Preemption

Last Updated: August 18 2016
Article by Jaimee B. Farrer

Here's another guest post, this time from Reed Smith's Elizabeth Graham Minerd. This post concerns PMA preemption, and a second opinion largely getting rid of a case that we blogged about before. As always, Elizabeth deserves all the credit, and any blame, for what follows. Without further ado:


In the recent decision of Marion v. Smith & Nephew, Inc., 2016 WL 4098608 (D. Utah July 27, 2016), the Court dismissed all but one of the plaintiffs' claims relating to a premarket approved medical device from the amended complaint. This was the Court's second time finding the plaintiffs' pleading largely deficient. This blog previously discussed the Court's first order dismissing plaintiffs' original complaint with leave to amend here. In that order, the Court provided the plaintiffs with a road map to navigating the "Scylla and Charybdis" of pleading a legally viable claim related to a premarket approved device. But even with a road map, the plaintiffs were only able to navigate one of their nine claims through Scylla and Charybdis and that one claim did not escape unscathed.

In Marion, the plaintiff was implanted with the defendant's hip resurfacing device—a device that received premarket approval a little over a year prior to the plaintiff's surgery. 2016 WL 4098608, at *1. After six years, the device allegedly failed and the plaintiff had it surgically removed. Id. The plaintiffs filed a lawsuit asserting various claims against the defendant for the device's purported failure. Id.

The Court dismissed the plaintiffs' original complaint, but granted the plaintiffs leave to amend. Id. In doing so, the Court provided "clear guidance" regarding the three issues that the plaintiffs would need to address in the amended complaint in order to state a parallel claim that would survive both preemption and Twombly/Iqbal [editorial note: regular bloggers call this "TwIqbal"]:

First the court required the [plaintiffs] to identify with specificity the federal law requirements that parallel the state law claims. Second, the court required the [plaintiffs] to identify with specificity the state law duties that existed prior to but allegedly parallel the requirements for the [device] under federal law. Finally, the [plaintiffs] were required to plead adequate facts to make their parallel state law claims plausible on their face.

Id. at *3.

With this road map in hand, the plaintiffs filed their amended complaint asserting nine claims against the defendant. But again, all but one of the plaintiffs' claims were left wrecked on the rocks or swallowed by the whirlpool.

Specifically, the plaintiffs' claims for strict products liability – manufacturing defect ran into both Twombly/ Iqbal and preemption. Id. at *5. The Court dismissed the manufacturing defect claim because (1) the plaintiffs "offer[ed] only conclusory allegations of alleged regulatory violations without any factual support" and (2) it would be preempted anyway to the extent the plaintiffs allege that the device as approved by the FDA was unreasonably dangerous. Id. So too plaintiffs' claims for strict products liability – failure to warn and negligent infliction of emotional distress ran into both Twombly/ Iqbal and preemption and were dismissed. Id. at *5-*6.

The plaintiffs' claim for breach of implied warranties crashed into express preemption and was dismissed because the FDA deemed the device fit for the purpose for which it had been approved and the plaintiffs' implied warranties claim necessarily attacked that determination. Id. at *6.

Meanwhile, the plaintiffs' claim for breach of express warranty collided with Twombly/Iqbal and was dismissed because the plaintiff failed to plead what express warranty was actually made to her prior to implantation of the device. Id. at *5. The plaintiffs' fraud based claims—negligent misrepresentation and fraudulent concealment—were smashed on the rocks of Rule 9 and were dismissed. Id. at *6. And the plaintiffs voluntarily dismissed their unfair and deceptive trade practices claim. Id.

The plaintiffs were only able to navigate their negligence claim through Scylla and Chaybdis, but even it did not survive unscathed. The Court narrowed the plaintiffs' negligence claim and rejected it to the extent that it was based on purported violations of regulations that the plaintiffs' counsel admitted did not apply to the device. Id. at *4. The Court further narrowed the plaintiffs' negligence claim and rejected it to the extent it was based on violations of regulations "asserted in conclusory fashion without any factual support to move the allegations from conceivable to plausible." Id. And the Court narrowed the plaintiffs' negligence claim even further and rejected it to the extent that it was based on "violations of federal regulations relate to conduct by the defendant during the PMA process prior to the final grant of PMA" because such allegations were no different than the fraud on the FDA theory rejected in Buckman Co. v. Plaintiffs' Legal Committee, 531 U.S. 341 (2001). Id.

The Court allowed a negligence claim based on alleged violations of the federal requirements relating to adverse event reporting to limp passed the defendant's motion to dismiss. Id. The Court found that the plaintiffs had raised a plausible inference that the defendant violated federal regulations relating to adverse event reporting based on allegations that there was a delay in the defendant receiving reports of adverse events and the defendant issued a voluntary recall. Id. at 5. However, the Court recognized that this claim will require plaintiffs to prove that the plaintiff's injuries would not have occurred or would have been mitigated had the defendant complied with these adverse event reporting regulations. Id. Since the plaintiff's implant surgery was only a year after approval, this will likely be an insurmountable causation hurdle.

The Court also allowed, but did not analyze, plaintiffs' negligence claim to the extent it is based on alleged violations of the federal requirements to train physicians and surgeons regarding the proper use of the device. Id. at *4. Notably, the Court did not mention any allegation that the device—which was in the plaintiff for six years before its alleged failure—had been implanted improperly by her surgeon.

Overall a solid win for the defense. Having had all but one of their claims wrecked by Scylla and Chaybdis, the plaintiffs now face a likely insurmountable causation hurdle.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.